IntroductionMetabolic syndrome, classified by co-occurrence of three of the following symptoms: insulin resistance, dyslipidemia, elevated inflammation and CRP levels, and abdominal obesity and affecting approximately 37% of the US population and 49% of those over 60, increases the risk of cardiovascular morbidity and mortality1. Excess calorie consumption and the resulting accumulation of fat in the liver cause the development of non-alcoholic fatty liver disease (NAFLD) in up to 75% of people ...